euglycemic

eu·gly·ce·mic

(yū'glī-sē'mik),
Denoting, characteristic of, or promoting euglycemia.
Synonym(s): normoglycemic

eu·gly·ce·mic

(yū'glī-sē'mik)
Denoting, characteristic of, or promoting euglycemia.
Synonym(s): normoglycemic, euglycaemic.
References in periodicals archive ?
The researchers identified 42 reports of euglycemic diabetes ketoacidosis (EDKA) and five cases of hyperglycemic diabetic ketoacidosis (HDKA) from 33 publications.
However, caution is needed because of the potential risk of euglycemic ketoacidosis, whose incidence was slightly increased with SGLT-2 inhibitors mainly in type 1 diabetes, sometimes provoked by alcohol excess, surgery, or intercurrent disease (30, 33, 34).
Rest 53% patients of frozen shoulder were found to be euglycemic. 41% patients had history of diabetes mellitus in their immediate family.
Inclusion criteria were: age older than eighteen years, newly diagnosed cases of ALL, euglycemic at diagnosis.
All these observations suggest that the genetically susceptible non-diabetic offspring of diabetic parents, even in their euglycemic state, have alterations in the autonomic regulation of cardiovascular system.
According to a revision carried out by Wallace et al (25) this surrogate had shown a good correlation when compared with the euglycemic clamp (r=0.58-0.88, p<0.0001).
Literature has exhibited that replacing vitamin D decreases HbA1c level and maintains euglycemic status.
The gold standard, euglycemic hyperinsulinemic clamping is clearly inadequate in view of its high cost and complexity.
(18,27) Concerns center around its osmotic diuretic effect, which can lead to dehydration, an increased frequency of genital infections, and, less commonly, euglycemic ketoacidosis.
The CHMP's decision was based on analytical similarity data, metabolic assays, and euglycemic clamp data in type 1 diabetes patients for demonstration of similar PD and PK response.
Data submitted as part of the Marketing Authorization Application included analytical similarity data, metabolic assays, euglycemic clamp data in type 1 diabetes patients for demonstration of similar PD and PK response, as well as robust clinical endpoint studies in patients with Type 1 and Type 2 Diabetes comparing Semglee with the reference product, insulin glargine to demonstrate similar safety, efficacy and immunogenicity up to 52 weeks.